2023-05-24
On the morning of May 23, 2023, Dahuanong Company and Guangzhou Bolin Company held the "Dahuanong New antipurgata and Gamihin Product Fair" in Longquan Resort Hotel, Xinhui, Guangdong Province, more than 50 dealers and group customer representatives gathered together to exchange product market prospects and sales strategies.
The new technology platform was adopted to increase the antigen content of PEDV, and the effective antigen content of PEDV reached 40ug/ head. The use of highly efficient adjuvants can effectively activate the receptor-mediated antibody transport mechanism, directly produce non-specific immunity, and activate the cell system to produce pinocytosis; It has the characteristics of good safety, high antigen content, prevention and treatment, rapid diarrhea and so on.
Gamixin - Gamimycin injection is a national class II new veterinary drug developed by Dahuanon. It is strong, broad-spectrum, quick-acting and long-acting, lung targeting, and is the terminator of respiratory diseases in pigs. The product is hydrophilic, oleophilic, and can be mixed with a variety of drugs, which can meet the clinical needs of a variety of drugs, and has remarkable effects on the treatment and health care of weaned piglets with blue ear disease positive.
The customers expressed high interest and attention to Nestacharb and Gamihin, and positively evaluated Dahuanong Company and Guangzhou Bolin Company for organizing the fair, and expressed their willingness to cooperate; We believe that the full range of support and services provided by the company has effectively helped customers achieve better performance and reputation in the market.